{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:29:45Z","timestamp":1780475385011,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370930"],"award-info":[{"award-number":["31370930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["13431900600"],"award-info":[{"award-number":["13431900600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["15XD1524900"],"award-info":[{"award-number":["15XD1524900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["KFJ-EW-STS-098"],"award-info":[{"award-number":["KFJ-EW-STS-098"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.033","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T12:08:16Z","timestamp":1472040496000},"page":"5005-5012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge"],"prefix":"10.1016","volume":"34","author":[{"given":"Chaoyun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.033_b0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/314032","article-title":"Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease","volume":"31","author":"Chan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.033_b0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.vaccine.2016.08.033_b0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.08.033_b0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11262-015-1239-0","article-title":"Complete genome sequence analysis of enterovirus 71 isolated from children with hand, foot, and mouth disease in Thailand, 2012\u20132014","volume":"51","author":"Mauleekoonphairoj","year":"2015","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2016.08.033_b0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.08.033_b0030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.033_b0035","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/JCM.01231-13","article-title":"Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China","volume":"51","author":"He","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0040","doi-asserted-by":"crossref","first-page":"e52073","DOI":"10.1371\/journal.pone.0052073","article-title":"Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009\u20132011","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1099\/0022-1317-68-4-1191","article-title":"Isolation and characterization of a cold-sensitive strain of Coxsackievirus A10","volume":"68","author":"Itagaki","year":"1987","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0050","doi-asserted-by":"crossref","first-page":"e84233","DOI":"10.1371\/journal.pone.0084233","article-title":"Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3","volume":"9","author":"Tian","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jmv.24151","article-title":"Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10","volume":"87","author":"Yang","year":"2015","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0060","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1111\/j.1469-0691.2012.03789.x","article-title":"Outbreak of hand, foot and mouth disease\/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study","volume":"18","author":"Mirand","year":"2012","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.vaccine.2016.08.033_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1525-1470.2010.01161.x","article-title":"Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses","volume":"28","author":"Davia","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0070","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2169\/internalmedicine.52.1042","article-title":"Neuromyelitis optica preceded by hyperCKemia and a possible association with coxsackie virus group A10 infection","volume":"52","author":"Okada","year":"2013","journal-title":"Internal Med"},{"key":"10.1016\/j.vaccine.2016.08.033_b0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcv.2011.12.011","article-title":"Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case","volume":"53","author":"Fuschino","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0080","first-page":"740","article-title":"Coxsackie A10 virus infection among infectious hepatitis contacts","volume":"93","author":"Embil","year":"1965","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2016.08.033_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcv.2010.02.002","article-title":"Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland","volume":"48","author":"Blomqvist","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098888","article-title":"Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012","volume":"9","author":"Puenpa","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1099\/jmm.0.036400-0","article-title":"Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India","volume":"61","author":"Gopalkrishna","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052073","article-title":"Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009\u20132011","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142733","article-title":"Etiology of multiple non-EV71 and non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009\u2013June 2013","volume":"10","author":"Guan","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0110","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/JCM.01231-13","article-title":"Emergence, circulation, and spatiotemporal phylogenetic analysis of Coxsackievirus A6-and Coxsackievirus A10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China","volume":"51","author":"He","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0115","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/j.vaccine.2010.02.095","article-title":"The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox","volume":"28","author":"Heinsbroek","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.033_b0120","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.033_b0125","article-title":"EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)","volume":"1\u20138","author":"Mao","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.08.033_b0130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.08.033_b0135","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.033_b0140","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.033_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.02.011","article-title":"Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice","volume":"129","author":"Zhang","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2016.08.033_b0150","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0155","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","volume":"31","author":"Cai","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.033_b0160","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4161\/hv.28083","article-title":"Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line","volume":"10","author":"Yang","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.08.033_b0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.02.008","article-title":"Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles","volume":"129","author":"Liu","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2016.08.033_b0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.08.033_b0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2012.09.024","article-title":"Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies","volume":"187","author":"Liu","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.08.033_b0180","first-page":"298","article-title":"A simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method","volume":"26","author":"Stanic","year":"1963","journal-title":"Pathol Microbiol (Basel)"},{"key":"10.1016\/j.vaccine.2016.08.033_b0185","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.033_b0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/biol.1995.0034","article-title":"Inactivation of DNA by beta-propiolactone","volume":"23","author":"Perrin","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2016.08.033_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of Coxsackie virus A16 viral particles","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0205","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0264-410X(95)00211-I","article-title":"Inactivated poliovirus vaccine: past and present experience","volume":"14","author":"Murdin","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.033_b0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jviromet.2013.04.020","article-title":"Comparison of initial feasibility of host cell lines for viral vaccine production","volume":"193","author":"Vlecken","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.08.033_b0215","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/bit.21109","article-title":"Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography","volume":"96","author":"Kalbfuss","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2016.08.033_b0220","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1128\/JVI.70.8.5519-5524.1996","article-title":"African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses","volume":"70","author":"Govorkova","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.033_b0225","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/pro.5560031005","article-title":"Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution","volume":"3","author":"Basavappa","year":"1994","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2016.08.033_b0230","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.033_b0235","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.033_b0240","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2006.06.083","article-title":"High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture","volume":"25","author":"Liu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.033_b0245","article-title":"Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T20:43:56Z","timestamp":1692477836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":49,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307058"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}